What is NDC 65841-780?

65841-780 is the product NDC for bupropion, Bupropion hydrochloride 300 mg/1 tablet, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 65841. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for bupropion?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

bupropion NDC 65841-780 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)65841-780Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65841-0780Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
65841-780-05	65841078005	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-780-05)Marketed from Feb 15, 2014
65841-780-06	65841078006	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-780-06)Marketed from Feb 15, 2014
65841-780-10	65841078010	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-780-10)Marketed from Feb 15, 2014
65841-780-16	65841078016	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-780-16)Marketed from Feb 15, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): bupropion
Generic name (nonproprietary): bupropion
Active ingredients: Bupropion hydrochloride — 300 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 65841
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201567
Marketing start: Feb 15, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Dopamine Uptake Inhibitors (Mechanism)Increased Dopamine Activity (Physiologic effect)Increased Norepinephrine Activity (Physiologic effect)Norepinephrine Uptake Inhibitors (Mechanism)
Identifiers: Product ID 65841-780_6c831525-a7c2-4ef1-b1b9-c7e8cb807dedSPL ID 6c831525-a7c2-4ef1-b1b9-c7e8cb807dedSPL set ID 78d34aad-9d4f-48c4-91eb-536e31c6b6c9RxCUI 993541, 993557UNII ZG7E5POY8O
Pharmacologic class: Aminoketone

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465841078005 followed by a unit qualifier and the quantity

Package 65841-0780-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 26, 2024.

Full label on DailyMed (opens in a new tab)

About NDC 65841-780

What is NDC 65841-780?: 65841-780 is the product NDC for bupropion, Bupropion hydrochloride 300 mg/1 tablet, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: bupropion.
What is the active ingredient?: Bupropion hydrochloride.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 65841. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for bupropion?: 7 other product NDCs are listed under this name. See all bupropion NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other bupropion NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
bupropionbupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Film coated, Extended releaseOral	Northwind Health Company, LLC	51655-357	51655-0357-2651655-0357-52
bupropion	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	65841-836	65841-0836-0565841-0836-0665841-0836-10+1 more
bupropion	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-353	68382-0353-0568382-0353-0668382-0353-10+1 more
bupropionbupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Proficient Rx LP	71205-565	71205-0565-3071205-0565-6071205-0565-90
bupropionbupropion hydrochloride	Bupropion hydrochloride 200 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	71335-0801	71335-0801-0171335-0801-0271335-0801-03+3 more
bupropion	Bupropion hydrochloride 300 mg/1	Tablet, Extended releaseOral	Proficient Rx LP	63187-521	63187-0521-3063187-0521-6063187-0521-90
bupropion	Bupropion hydrochloride 300 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-354	68382-0354-0568382-0354-0668382-0354-10+1 more

Other NDCs under ANDA 201567

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201567
Product	Strength	Form · route	Labeler	Product NDC
bupropion	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-353
bupropion	Bupropion hydrochloride 300 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-354
bupropion	Bupropion hydrochloride 300 mg/1	Tablet, Extended releaseOral	Proficient Rx LP	63187-521
bupropion	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	65841-836